HOLX : Summary for Hologic, Inc. - Yahoo Finance

U.S. Markets open in 8 hrs.

Hologic, Inc. (HOLX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
40.00+0.47 (+1.19%)
At close: 4:00PM EST
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close39.53
Bid39.95 x 200
Ask42.33 x 100
Day's Range39.21 - 40.01
52 Week Range32.64 - 41.24
Avg. Volume2,515,267
Market Cap11.17B
PE Ratio (TTM)34.19
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire5 days ago

    FDA Grants PMA Approval for Hologic's Aptima® Hepatitis C Quant Dx Assay

    MARLBOROUGH, Mass., Feb. 15, 2017 /PRNewswire/ -- Hologic, Inc. (HOLX) announced today that the United States Food and Drug Administration (FDA) has granted PMA approval for the Company's hepatitis C virus (HCV) assay for quantitation of HCV viral load and confirming active HCV infection on the fully automated Panther® system. "HCV therapeutic options continue to evolve rapidly with highly effective antiviral medications that are transforming treatment of the disease, with cure rates above 90%," said Tom West, president, Diagnostic Solutions Division at Hologic.

  • Investopedia6 days ago

    Hologic to Acquire Cynosure for $1.65 Billion

    Hologic is acquiring Cynosure to expand into the growing medical aesthetics field.

  • Cynosure (CYNO) to be Acquired by Hologic in $1.65B Deal
    Zacks6 days ago

    Cynosure (CYNO) to be Acquired by Hologic in $1.65B Deal

    Cynosure, Inc. (CYNO), announced that it has entered into a definitive merger agreement with Hologic, Inc. (HOLX).